Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 18, 2002

View Archived Issues

Inhibition of breast cancer cell growth in vitro with c-myc oligonucleotides and ICI-182780

Novel anticancer therapy: paclitaxel combined with an MEK inhibitor enhances apoptosis

Topical liposomal tacrolimus effective in murine model of immune-mediated skin disorders

Keratinocytes from papillomavirus-infected skin express antimicrobial peptide

Antiangiogenic effects of zoledronic acid demonstrated in vitro and in vivo

Novel HIV protease inhibitors identified at Pharmacor

Toagosei presents novel ammonium salts with antibacterial, antifungal and antiprotozoal activity

Novel CRF antagonists and their use in depression, anxiety, etc.

cGMP-selective PDE inhibitors under study at Bayer

New zinc complexes with dual activity as insulin mimetics and antihypertensive agents

Novel PDE5 inhibitors developed by Lilly Icos researchers

Japan Energy describes TNF-alpha and IL-6 production inhibitors

Memory-improving compounds covered by Zenyaku Kogyo patent

Bayer Diagnostics completes Visible Genetics acquisition

ActivBiotics and DepoMed to develop rifalazil for gastrointestinal bacterial infections

New class of compounds for drug-resistant HIV discovered at Pharmacor

Additional data reported on the efficacy and safety of aripiprazole in schizophrenia

Inhibitors of two-component regulatory system as potentially novel antibacterial agents

Ras inhibitor FTS reduces autoantibodies in animal models of APS

EGFR-targeted MAb improves response to radiotherapy in SCCHN

Doxovir 1% eliminates HPV11 from foreskin grafts in mouse model

Epicyte receives grant for production of HIV hybrid antibodies

FluINsure challenge study cleared in U.K.

Long-term safety data for RG-1068

German approval for Ezetrol

Columbia and Ardana enter European marketing partnership for Striant

Canadian IND cleared for Generex's buccal fentanyl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...